SSStefanny Karla Ferreira de Sousa

Stefanny Karla Ferreira de Sousa

*This is an algorithmically generated author record based on publicly available information.

Stefanny Karla Ferreira de Sousa has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    What are the scientific facts about the symptoms and treatment of COVID-19 in the pediatric population? A systematic review with overview

    by Vitória Monteiro Monte Oliveira, Paulo Francisco de Almeida-Neto, Francisca Dalila Paiva Damasceno de Lima, Stefanny Karla Ferreira de Sousa, André Carvalho de Sousa, Ruth Silva Galdino, Dihogo Gama de Matos, Alexandre Bulhões-Correia, Breno Guilherme de Araújo Tinôco Cabral, Glaucia Posso Lima

    Considering the lower prevalence of pediatric patients with COVID-19, health professionals are more familiar with interventions aimed at adults; thus, understanding the symptoms and which approaches can be useful for pediatric patients with COVID-19 is of great importance for health professionals. The study aimed to aggregate scientific data on procedures and treatments performed on pediatric patients (aged 6 to 17 years) with COVID-19. A systematic literature search was performed in five electronic databases (i.e., PubMed, CINAHL, Google Scholar, and LILACS). Literature analyses were performed in English and Chinese, between November 2019 and December 2020. For data classification, the web application Rayyan® was used. Studies have shown that in most cases, children are asymptomatic. However, when symptomatic, they present fever, cough, intestinal infection, and vomiting. It is noteworthy that the respiratory rate and stool tests were significant indicators of the disease. Regarding treatment, oxygen support is essential during the hospitalization of patients and, antiviral therapy with Lopinavir and Ritonavir has shown significant results in a few isolated cases. It is concluded that the main symptoms of SARS-CoV-2 in pediatric patients are mild symptoms similar to those of common flu. In addition, respiratory rate and examinations based on fecal samples are good indicators of the disease in children of both sexes, as well as antiviral therapies and early isolation at the beginning of the disease are significant for the healing process.

  • Open Access

    COVID 19-How is the Exposure of the Pediatric Population? A Systematic Review Protocol

    by Vitória Monteiro Monte Oliveira, Paulo Francisco de Almeida-Neto, Francisca Dalila Paiva Damasceno de Lima, Stefanny Karla Ferreira de Sousa, André Carvalho de Sousa, Ruth Silva Galdino, Dihogo Gama de Matos, Breno Guilherme de Araújo Tinôco Cabral, Glaucia Posso Lima

    Solid information on exposure and how to treat COVID-19 in pediatric patients is not yet conclusive in the literature, because of this it is necessary to make a critical analysis of the available data in order to provide common points on the theme in question. This systematic review protocol is registered in PROSPERO (ID: CRD42020181835) and aims through searches in the Databases PubMed, Google Scholar, LILACS and CINAHL, to group the studies published with the theme COVID-19 and pediatric between 2019 and 2020. The MeSH descriptors: COVID-19, child and children will be used in English and Chinese. Observational research, clinical trials and literature reviews will be included, where the study sample was composed of pediatric patients of both sexes aged between 6 and 17 years. The Rayyan QCRI tool® will be used to manage revision data. The analysis of the feasibilities of observational studies will be done by the Loney scale, clinical trials by the Cocharne scale and review studies by the Overview Quality Assessment Questionnaire (OQAQ). The authors intend that the study is completed in the second semester of 2021. The choice of the theme is justified because the results of the future research are useful for the elaboration of public health measures that offer the promotion of effective treatment during the recovery of pediatric patients infected with COVID-19.